Urogen Pharma Ltd. buy ReynadJ
Start price
15.06.24
/
80%
€18.20
Target price
15.06.25
-
Performance (%)
-18.13%
Price
22.07.24
€14.90
Summary
This prediction is currently active. The prediction for Urogen Pharma Ltd. disappoints with a performance of -18.13%. This prediction currently runs until 15.06.25. The prediction end date can be changed by ReynadJ at any time. ReynadJ has 80% into this prediction This prediction was marked as speculative and is excluded from ReynadJ's performance statistics.Performance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Urogen Pharma Ltd. | - | - |
| iShares Core DAX® | -0.116% | 1.953% |
| iShares Nasdaq 100 | -2.733% | -1.273% |
| iShares Nikkei 225® | -1.721% | 3.263% |
| iShares S&P 500 | -1.527% | 0.194% |
According to ReynadJ what are the pros and cons of Urogen Pharma Ltd. for the foreseeable future?
Pros
EBIT growth >5% per year expected
Could be worthwhile Investment >10% per year
Good rating
ROE higher than 10% per year
Fair valuation
Cons
Risky balance sheet
Comments by ReynadJ for this prediction
In the thread Urogen Pharma Ltd. diskutieren
Buy Urogen Pharma Ltd.